Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12423276rdf:typepubmed:Citationlld:pubmed
pubmed-article:12423276lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0001899lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0035525lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:12423276lifeskim:mentionsumls-concept:C1882115lld:lifeskim
pubmed-article:12423276pubmed:issue12lld:pubmed
pubmed-article:12423276pubmed:dateCreated2002-11-8lld:pubmed
pubmed-article:12423276pubmed:abstractTextDecreased alanine aminotransferase (ALT) level is the accepted basic indicator of an interferon (IFN) therapeutic effect in chronic hepatitis C. This study assessed whether delayed normalization of ALT predicts a poor response to a combined therapy of IFN and ribavirin in patients with chronic hepatitis C virus (HCV) infection.lld:pubmed
pubmed-article:12423276pubmed:languageenglld:pubmed
pubmed-article:12423276pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:citationSubsetIMlld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12423276pubmed:statusMEDLINElld:pubmed
pubmed-article:12423276pubmed:monthDeclld:pubmed
pubmed-article:12423276pubmed:issn0815-9319lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:LeeChuan-MoCMlld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:LuSheng-NanSNlld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:ChenChien-Hun...lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:ChangchienChi...lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:WangJing-Houn...lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:HungChao-Hung...lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:ChenTsung-Min...lld:pubmed
pubmed-article:12423276pubmed:authorpubmed-author:TungHung-DaHDlld:pubmed
pubmed-article:12423276pubmed:copyrightInfoCopyright 2002 Blackwell Publishing Asia Pty Ltdlld:pubmed
pubmed-article:12423276pubmed:issnTypePrintlld:pubmed
pubmed-article:12423276pubmed:volume17lld:pubmed
pubmed-article:12423276pubmed:ownerNLMlld:pubmed
pubmed-article:12423276pubmed:authorsCompleteYlld:pubmed
pubmed-article:12423276pubmed:pagination1307-11lld:pubmed
pubmed-article:12423276pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:meshHeadingpubmed-meshheading:12423276...lld:pubmed
pubmed-article:12423276pubmed:year2002lld:pubmed
pubmed-article:12423276pubmed:articleTitleIs delayed normalization of alanine aminotransferase a poor prognostic predictor in chronic hepatitis C patients treated with a combined interferon and ribavirin therapy?lld:pubmed
pubmed-article:12423276pubmed:affiliationDivision of Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Taiwan.lld:pubmed
pubmed-article:12423276pubmed:publicationTypeJournal Articlelld:pubmed